Adjusting win statistics for dependent censoring-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adjusting win statistics for dependent censoring

Published:2020-11-28 Issue:3 Volume:20 Page:440-450
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceutical Statistics

Author:

Dong Gaohong¹^ORCID,Huang Bo²^ORCID,Wang Duolao³,Verbeeck Johan⁴^ORCID,Wang Jiuzhou⁵,Hoaglin David C.⁶^ORCID

Affiliation:

1. iStats Inc. Long Island City New York USA

2. Pfizer Inc. Groton Connecticut USA

3. Liverpool School of Tropical Medicine Liverpool UK

4. DSI, I‐Biostat University Hasselt Hasselt Belgium

5. ImmunoGen Inc. Waltham Massachusetts USA

6. Department of Population and Quantitative Health Sciences University of Massachusetts Medical School Worcester Massachusetts USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.2086

Reference34 articles.

1. The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities

2. Generalized pairwise comparisons of prioritized outcomes in the two-sample problem

3. The Win Ratio: On Interpretation and Handling of Ties

4. Combining mortality and longitudinal measures in clinical trials

5. Generalized pairwise comparison methods to analyze (non)prioritized composite endpoints

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining estimand for the win ratio: Separate the true effect from censoring;Clinical Trials;2024-07-30

2. Win Statistics in Observational Cancer Research: Integrating Clinical and Quality-of-Life Outcomes;Journal of Clinical Medicine;2024-05-31

3. Win Statistics in Pulmonary Arterial Hypertension Clinical Trials;American Journal of Respiratory and Critical Care Medicine;2023-12-01

4. Adjusted win ratio using the inverse probability of treatment weighting;Journal of Biopharmaceutical Statistics;2023-11-10

5. Use of Win Statistics to Analyze Outcomes in the DAPA-HF and DELIVER Trials;NEJM Evidence;2023-10-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3